Recap: Medical Affairs Launch Planning Webinar

Natalie DeMasi, clinical development and medical affairs researcher
By Natalie DeMasi,
Senior Research Analyst

Medical affairs is on the front lines of a product launch.  During this crucial launch window, medical affairs is responsible for raising awareness, educating stakeholders and all-around readying the healthcare community.  These tasks make medical affairs a cornerstone of product success.  However, medical affairs teams are only as effective as their product launch plan, as poor timing or a sub-par strategy can diminish their impact. Continue reading



MSL Selection: Expertise, Knowledge and A Certain Je Ne Sais Quoi

Sarah Ray, regulatory affairs and safety researcher
By Sarah Ray,
Senior Research Analyst

Medical science liaisons (MSLs) are often a key ingredient of life science teams’ medical strategy.  For some teams, the MSL hiring process can be arduous as companies focus on qualifications that they believe will make prospective MSLs successful at their organization.  To help them recruit and retain well-suited MSL candidates, companies may look to individuals that balance expertise with enthusiasm. Continue reading



Medical Affairs and Postmarketing Studies Go Together Like Peas and Carrots

Sarah Ray, regulatory affairs and safety researcher
By Sarah Ray,
Senior Research Analyst

Postmarketing studies help companies expand their product knowledge, even after the launch window has passed.  For example, dedicated or non-dedicated postmarketing study teams may leverage Phase 4 research to gather additional safety data as a condition of regulatory approval. Or, companies may develop postmarketing studies to evaluate the impact of long-term product use.  Still other life science organizations may generate late-stage studies as a way to demonstrate cost-effectiveness.  Regardless of their end goal, companies can gather information to fulfill these diverse objectives through prospective interventional or observational studies or through retrospective data collection methods. Continue reading


Medical Affairs Firewalls: How Far Is Too Far?

Natalie DeMasi, clinical development and medical affairs researcher
By Natalie DeMasi,
Senior Research Analyst

Compliance can be medical affairs’ worst enemy.  In fact, our new medical affairs report found that compliance and perceived overregulation were the most commonly-reported concerning trends among surveyed industry experts.  Compliance concerns include managing off-label discussions and fair market value payments to physicians.  However, internal firewalls between medical affairs teams and commercial teams can also be a point of contention at many companies. Continue reading


What Level Executive Should Lead Your Medical Science Liaison Team?

Natalie DeMasi, clinical development and medical affairs researcher
By Natalie DeMasi,
Senior Research Analyst

Organizing medical science liaison teams can be a struggle.  At Cutting Edge Information, we have interviewed numerous MSL leaders and each interviewee’s team is unique.  Some teams focus on interteam communication worldwide, and others operate in smaller silos.  Some teams handle multiple products in one therapeutic area, and others manage one product with multiple indications.  Many teams do not even use the “medical science liaison” moniker.  Among these differences, MSL teams are also split about the title of their MSL head. Continue reading


Medical Publications Teams Begin Activities As Early As Pre-Clinical

Natalie DeMasi, clinical development and medical affairs researcher
By Natalie DeMasi,
Senior Research Analyst

Medical publications groups are the forerunners of product success.  The clinical development team spends years testing a potential product and collecting data about its efficacy and safety.  But, the medical publications team has the privilege of formulating these findings into articles and disseminating them via journals.  In fact, medical publications teams are so vital that surveyed global medical affairs teams allocate an average 14% of their budgets to medical publications. Continue reading


The Next Medical Affairs Innovation: Patient-Centricity

Natalie DeMasi, clinical development and medical affairs researcher
By Natalie DeMasi,
Senior Research Analyst

Over the last decade, medical affairs has been transitioning from an offshoot of marketing into an independent function that is vital in its own right.  As a part of this transformation, medical affairs teams have found ways to innovate — going above and beyond to bring the most value to healthcare stakeholders and the internal organization.  Cutting Edge Information’s new medical affairs report uncovered many new medical affairs innovations, and one of the most exciting trends is a drive towards patient centricity. Continue reading


Medical Science Liaisons: Case Studies for Promoting Interteam Communication

Natalie DeMasi, clinical development and medical affairs researcher
By Natalie DeMasi,
Senior Research Analyst

Medical science liaisons (MSLs) have all types of interesting, difficult and/or successful encounters with healthcare providers (HCPs).  MSLs can learn from hearing each other’s stories and together create best practices for overcoming challenging situations — and not just MSLs that are on the same team but MSLs throughout the entire company.  Despite the benefits of these conversations, 39% of surveyed MSL teams face challenges with internal communication (Figure 1). Continue reading